Clínic Barcelona
Health Topics

The first product derived from faecal microbiota is approved

The US Food and Drug Administration (FDA) has approved the first faecal microbiota-derived product for the treatment of infection with Clostridioides difficile, a bacterium that causes diarrhoea and inflammation of the colon.

faecal microbiota pill

The new product is defined as a faecal microbiota product obtained from qualified donors who have to pass the screening.

Keep reading about:

Related news